PERSPECTA

News from every angle

← Back to headlines

Jim Cramer Supports Eli Lilly Amidst GLP-1 Lawsuit

Financial analyst Jim Cramer has reiterated his support for Eli Lilly, even as the pharmaceutical company faces a GLP-1 lawsuit from a rival, explaining his reasons to investors.

21 Jul, 16:40 — 21 Jul, 16:40
PostShare

Sources

Showing 1 of 1 sources
cnbcMostly Factual27d ago

Jim Cramer says he's standing by Eli Lilly after rival's GLP-1 lawsuit. Here's why

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.

Read full article →

Related Stories

Netflix Stock Valuation Debate: Undervalued or Value Trap?

50m ago

Ferrari's First Electric Car, Luce, Sells for Record $40 Million at Auction

1h ago

OpenAI Investors Consider Latest CFO Comments

1h ago

Synchrony Partners with OpenAI for AI Shopping Integration

1h ago